AEMD insider forfeits 1,786 shares to cover tax from RSU conversion

Chetan Shah, a director of Aethlon Medical, Inc. (AEMD), reported a transaction on 09/30/2025 in which 1,786 shares of common stock were forfeited to cover tax withholdings arising from the conversion of 4,465 vested restricted stock units into common shares.

Rhea-AI Filing Summary

Chetan Shah, a director of Aethlon Medical, Inc. (AEMD), reported a transaction on 09/30/2025 in which 1,786 shares of common stock were forfeited to cover tax withholdings arising from the conversion of 4,465 vested restricted stock units into common shares. The filing shows a per-share price used for the withholding calculation of $0.749. After the withholding, the reporting person beneficially owned 22,672 shares of common stock. The restricted stock units forfeited were part of a grant previously reported by the reporting person in an earlier Form 4 filed in April 2025.

Insider Trade Summary

Exercise Price or Tax Liability: 1,786 shares

Exercise Price or Tax Liability 1 txn

Insider Shah Chetan

Role Director

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	1,786	$0.749	$1K

Holdings After Transaction: Common Stock — 22,672 shares (Direct)

Footnotes (1)

1. F1. The Reporting Person forfeited 1,786 shares of common stock upon conversion of an aggregate 4,465 vested and outstanding restricted stock units into shares of common stock to cover tax withholdings, using the market price of the issuer's common stock at the time of forfeiture. These restricted stock units were part of the grant reported in Table I of the Form 4 filed by the Reporting Person with the Securities and Exchange Commission on April 25, 2025.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What transaction did AEMD director Chetan Shah report on Form 4?

The report discloses the forfeiture of 1,786 common shares to satisfy tax withholdings when 4,465 vested restricted stock units converted into shares.

How many shares does Chetan Shah beneficially own after the transaction?

Following the reported transaction, the reporting person beneficially owned 22,672 shares of AEMD common stock.

What price was used to calculate the tax withholding on the forfeited shares?

The market price used for the withholding calculation was $0.749 per share.

Were the forfeited shares part of a new award?

No; the restricted stock units converted were part of a grant previously reported by the reporting person in a Form 4 filed in April 2025.

What was the transaction date listed for the conversion and forfeiture?

The transaction date shown in the Form 4 is 09/30/2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/02/2025 - 04:15 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Shah Chetan

(Last) (First) (Middle)

11555 SORRENTO VALLEY ROAD, SUITE 203

(Street)

SAN DIEGO CA 92121

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AETHLON MEDICAL INC [ AEMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/30/2025		F		1,786(1)	D	$0.749	22,672	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The Reporting Person forfeited 1,786 shares of common stock upon conversion of an aggregate 4,465 vested and outstanding restricted stock units into shares of common stock to cover tax withholdings, using the market price of the issuer's common stock at the time of forfeiture. These restricted stock units were part of the grant reported in Table I of the Form 4 filed by the Reporting Person with the Securities and Exchange Commission on April 25, 2025.

	/s/ Chetan Shah, M.D. by: James B. Frakes, Attorney-in-fact	10/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.